Coherus BioSciences Inc (CHRS)
2.27
+0.10
(+4.61%)
USD |
NASDAQ |
May 03, 16:00
2.27
0.00 (0.00%)
Pre-Market: 08:05
Coherus BioSciences Total Assets (Quarterly): 629.60M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 629.60M |
| September 30, 2023 | 583.78M |
| June 30, 2023 | 469.59M |
| March 31, 2023 | 402.43M |
| December 31, 2022 | 480.85M |
| September 30, 2022 | 550.91M |
| June 30, 2022 | 546.00M |
| March 31, 2022 | 593.39M |
| December 31, 2021 | 679.33M |
| September 30, 2021 | 741.73M |
| June 30, 2021 | 739.54M |
| March 31, 2021 | 693.30M |
| December 31, 2020 | 841.65M |
| September 30, 2020 | 803.73M |
| June 30, 2020 | 756.61M |
| March 31, 2020 | 466.54M |
| December 31, 2019 | 408.93M |
| September 30, 2019 | 327.38M |
| June 30, 2019 | 240.46M |
| March 31, 2019 | 186.12M |
| Date | Value |
|---|---|
| December 31, 2018 | 99.47M |
| September 30, 2018 | 141.46M |
| June 30, 2018 | 188.31M |
| March 31, 2018 | 128.46M |
| December 31, 2017 | 162.61M |
| September 30, 2017 | 189.76M |
| June 30, 2017 | 172.25M |
| March 31, 2017 | 227.50M |
| December 31, 2016 | 178.48M |
| September 30, 2016 | 192.36M |
| June 30, 2016 | 251.10M |
| March 31, 2016 | 226.24M |
| December 31, 2015 | 212.38M |
| September 30, 2015 | 202.31M |
| June 30, 2015 | 249.55M |
| March 31, 2015 | 153.15M |
| December 31, 2014 | 187.22M |
| September 30, 2014 | 129.18M |
| June 30, 2014 | 122.18M |
| December 31, 2013 | 47.45M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
240.46M
Minimum
Jun 2019
841.65M
Maximum
Dec 2020
576.62M
Average
583.78M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| AbbVie Inc | 148.87B |
| Inovio Pharmaceuticals Inc | 170.95M |
| Nektar Therapeutics | 398.03M |
| Avid Bioservices Inc | 455.23M |
| Stereotaxis Inc | 41.91M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 823.03M |
| Shareholders Equity (Quarterly) | -193.42M |
| Debt to Equity Ratio | -2.447 |
| Current Ratio | 1.434 |
| Net Debt Paydown Yield | -0.15% |